Value-based care, the healthcare model designed to incentivize providers to improve patient recovery and reduce costs is not news in California as the state is an early adopter of the Affordable Care Act. The shift is also changing the approach to new product adoption. Altura’s CEO Pete Fronte has noted a consistent rise in the number of post-FDA approval clinical studies of medication and devices. SEE MORE (opens PDF for review or download)